ArticleLeukemia2015

Should we also evaluate SET together with CIP2A for the treatment with second-generation tyrosine kinase inhibitors in chronic myeloid leukemia?

I Cristóbal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.